Has Wendy Burnette received payments from drug or device companies?

Yes. Drug and device makers reported $7,553 in general payments to Wendy Burnette across 203 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wendy Burnette did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wendy Burnette come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wendy Burnette

Psychiatric/Mental Health · Hamilton, OHNPI 1801219357

Payments from drug & device makers

$7,553in general payments, 2019–2025

Across 203 payments — averaging $37.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teva Pharmaceuticals USA, Inc.$2K
Alkermes, Inc.$1K
Otsuka America Pharmaceutical, Inc.$1K
Johnson & Johnson$920
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$482
Axsome Therapeutics, Inc.$378
plus $987 from 11 others

What the payments were for

Food & beverage$7,528100%
Education$260%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	40	$2,112
Alkermes, Inc.	65	$1,365
Otsuka America Pharmaceutical, Inc.	24	$1,309
Johnson & Johnson	20	$920
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	10	$482
Axsome Therapeutics, Inc.	4	$378
Neurocrine Biosciences, Inc.	11	$224
AbbVie	7	$198
Lundbeck LLC	10	$166
Luye Pharma (USA) Ltd.	1	$121
Vanda Pharmaceuticals Inc.	1	$104
E.r. Squibb & Sons, L.L.C.	3	$53
Sunovion Pharmaceuticals Inc.	2	$35
Indivior Inc.	2	$32
Supernus Pharmaceuticals, Inc.	1	$19
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$19
Takeda Pharmaceuticals U.S.A., Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,553 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
IngrezzaValbenazine Tosylate	23	$188,815
Abilify MaintenaAripiprazole	14	$45,835
Invega SustennaPaliperidone Palmitate	24	$41,971
VyvanseLisdexamfetamine Dimesylate	19	$7,515
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	23	$3,855
Clozapine	13	$2,836
Trazodone Hcl	64	$2,188
Buspirone Hcl	45	$1,469
Hydroxyzine Hcl	54	$1,301
Quetiapine Fumarate	125	$1,286
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	46	$1,193
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl	12	$1,114
Aripiprazole	30	$1,023
Oxcarbazepine	12	$908
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	12	$853

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza	$224	$188,81523 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena	$1,309	$45,83514 claims
Johnson & JohnsonInvega Sustenna	$920	$41,97124 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse	$16	$7,51519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Hamilton

Crystal TravisJackson$333K
Kristina RoweIronton$253K
Patricia SparksPortsmouth$210K
Mary HallWarren$195K
Kassandra KornbauCanfield$170K
Terri PopovitzCincinnati$161K
Steven MatesDayton$121K
Robert ParsonsYoungstown$119K
Chriscia BaneChillicothe$115K
Rachael McLaughlinMaple Heights$114K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →